How many clinical trials are tracked of Avacincaptad pegol?

6 trials are tracked, 2 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

Avacincaptad pegol

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of Avacincaptad pegol

6 trials tracked of Avacincaptad pegol: 3 in phase 3 or 4 and 2 with published results. The most-cited published study has 438 citations.

6Trials tracked

3Phase 3 & 4

0Recruiting

2With published results

Phase distribution

Phase 3 3 Phase 2 3

Phase 3 Zimura in Participants With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration Completed · 438 cited
Phase 3 A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) Completed · 311 cited
Phase 3 Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy Completed
Phase 2 A Study to Establish the Safety and Tolerability of Zimura™ (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV) Completed
Phase 2 ZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD) Completed
Phase 2 Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1) Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.